Year: 2023
Type: dissertation
Study design: Observational Study
Abstract: The Alzheimer`s disease (AD) is the main reason for dementia. The future will show an increase of this illness, because of the demographic change. The whole pathomechanism is still unknown. The knowledge of the pathomechanism is important to develop an early therapy against neurodegeneration in AD. Additionally, it is very crucial to develop biomarkers for an early diagnosis. Here we examine the potential of microvesicles (MV) in the blood as a biomarker for AD. MV are released from cells and have a size from 100 to 1000 nanometre (nm). They contain cytoplasm and have a cell membrane. Their surface shows different proteins like their releasing cell. Maybe here we can get information about the place of pathomechanism. We examined MV in blood samples from patients with AD and controls with flow cytometry. To only measure the MV and to reduce the background, we used different practical and technical tools. The results are showing a significant increase of CD31 positive MV in the blood samples of patients with AD compared to the controls. CD69 positive MV are showing a significant decrease of the main fluorescent intensity (MFI) in the group of patients with AD. Some other measured surface proteins on MV are showing no differences in the blood samples of the AD group compared to the controls. The results show that MV have the potential to give information about a disease. They also seem to give information about the AD. This will be shown and discussed in the following parts. The isolation of MV from blood samples contains physiological variables and technical challenges that will be represented and discussed.
Author: Fuchs, Christina
Institution: Friedrich-Alexander-Universität Erlangen-Nürnberg
Language: German
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7011519434
